Latest news

Webinar – QC Biologics Solutions using Long-Read Sequencing

Watch our webinar to learn the insights from our industry experts on QC Biologics Solutions using Long-Read Sequencing.

Silence of the genes: the relation between gene methylation and its expression.

Read our blog on DNA methylation's role in regulation to explore cancer implications & advanced detection methods.

White paper: quality control of biologics – precision safety through long-read sequencing

Read our white paper on long-read sequencing for biologics QC, with case studies showcasing genetic variant accuracy.

Companion Diagnostics: Importance, Technologies, and Regulatory Landscape

Learn about the key differences between IVD and LDT, the impact of the new IVDR, and the promising role of epigenetics a ...

Elevate your genomic discoveries with Nanopore Sequencing

What is Nanopore Sequencing? Nanopore sequencing is a third- generation sequencing technology (TGS) that

The incredible power of RNA sequencing

What is RNA sequencing? RNA sequencing (RNA-seq) is a powerful technique used to analyze the transcriptome, which refers ...

OHMX.bio PARTNERS AT THE WORLD CB-CDx SUMMIT in BOSTON

This year we’re partnering at the 13th Clinical Biomarkers & CDx World 2023 conference in Boston, US. Our ...

EXCITING NEWS: renewed ISO-9001 and ISO-27001 certification!

ūüď£ Exciting News! ūüŹÜ We are thrilled to announce that we have once again achieved the ISO-9001 and ISO-27001 certifi ...

OHMX.bio is off to London for the CB CDx meeting

This year we’re sponsoring the 13th¬†Clinical Biomarkers & CDx Europe 2023 conference. Our CSO and Co-founder, ...

OHMX.bio is branching out: CDx on demand

To respond to growing demand from the biotech and the diagnostic field for partnerships with expertise in diagnostic ass ...

Upcoming events

OHMX.bio PARTNERS AT THE WORLD CB-CDx SUMMIT in BOSTON

This year we’re partnering at the 13th Clinical Biomarkers & CDx World 2023 conference in Boston, US. Our ...

OHMX.bio is off to London for the CB CDx meeting

This year we’re sponsoring the 13th¬†Clinical Biomarkers & CDx Europe 2023 conference. Our CSO and Co-founder, ...

Nanopore day 2022: OHMX.bio took home an award

During the Nanopore Day 2022 in Ghent, our Iuliana Vintea, VLAIO Baekeland PhD fellow of OHMX.bio, gave a presentation o ...

OHMX.bio is presenting at Life-on-chip event

Our CSO and Co-founder, Gerben Menschaert, is presenting at the “Life-on-chip” virtual conference in th ...

Swiss BioTech Day 2021: April 20, Basel (Swiss)

Karine Clauwaert, director Business Development and Gerben Menschaert, CSO, will be attending the Swiss biotech day in 2 ...

Knowledge for Growth 2020: September 10, Ghent (Belgium)

OHMX.bio its team members, Karine Clauwaert and Gerben Menschaert will be attending the Flanders.bio Knowledge for growt ...

Innovation For Health 2021: April 16-17, Rotterdam, (The Netherlands)

OHMX.bio will be attending Innovation for Health in 2021 Innovation for Health is the leading conference for key playe ...